![](https://weeklysauce.com/wp-content/uploads/2019/03/depressed_teen53.jpg)
The U.S. Food and Drug Administration on Tuesday approved the nasal spray medication esketamine — a relative of the club drug and anesthetic ketamine — for use against severe depression. Sold as Spravato, the fast-acting drug becomes the first new type of medicine approved in years against an illness that plagues millions of Americans. In… read on >